share_log
  • Headlines
  • shandong jincheng pharmaceutical group (300233.SZ) released its performance for the first three quarters, with a net income of 0.151 billion yuan, an increase of 14.02%.

金城医药(300233.SZ)发布前三季度业绩，净利润1.51亿元，增长14.02%

shandong jincheng pharmaceutical group (300233.SZ) released its performance for the first three quarters, with a net income of 0.151 billion yuan, an increase of 14.02%.

Zhitong Finance ·  Oct 24 17:54

Shandong Jincheng Pharmaceutical Group (300233.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters being 2...

Smart Finance News App, Shandong Jincheng Pharmaceutical Group (300233.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters decreasing by 2.08% to 2.515 billion yuan. Net income attributable to shareholders of the listed company increased by 14.02% to 0.151 billion yuan, while net income attributable to shareholders of the listed company excluding non-recurring gains and losses increased by 15.90% to 0.138 billion yuan. Basic earnings per share was 0.4 yuan.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated